GPX4 and pancreatic neoplasm: A group led by Yuan Wang demonstrated that the acetylation of HSPA5 by EP300 amplified the HSPA5-induced suppression of GPX4, leading to heightened lipid peroxidation and ferroptosis in pancreatic cancer (Wang Y. et al., 2023).